Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Tyra Biosciences Initiates SURF201 Phase 1 Study And Doses First Patient With TYRA-200; Co. Also Received FDA Feedback On TYRA-300 Phase 2 ACH Study, Says IND Submission Planned For 2H 2024

Author: Benzinga Newsdesk | December 22, 2023 10:01am

Posted In: TYRA